1-3 of 3
Carrie Ma
Close
Save search
Sort by
Journal Articles

Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).

Free
Partow Kebriaei, MD, Rima M. Saliba, PhD, Carrie Ma, Cindy Ippoliti, PharmD, Daniel R. Couriel, MD, Marcos de Lima, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, James L. Gajewski, MD, Chul S. Ha, MD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2005) 106 (11): 1135.
https://doi.org/10.1182/blood.V106.11.1135.1135
Published: 2005
Journal Articles

The Impact of Rituximab in the Development of Acute Graft Versus Host Disease (GVHD) Following Allogeneic Stem Cell Transplantation (SCT) for Acute Lymphoblastic Leukemia (ALL).

Free
Partow Kebriaei, MD, Rima M. Saliba, PhD, Carrie Ma, Cindy Ippoliti, PharmD, Daniel R. Couriel, MD, Marcus de Lima, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, James L. Gajewski, MD, Chul S. Ha, MD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2005) 106 (11): 1803.
https://doi.org/10.1182/blood.V106.11.1803.1803
Published: 2005
Journal Articles

Allogeneic Transplantation for Adult Acute Lymphoblastic Leukemia (ALL) with Rituximab or Campath I-H.

Free
Issa F. Khouri, MD, Rima M. Saliba, PhD, Partow Kebriaei, MD, Carrie Ma, Cindy Ippoliti, PharmD, Daniel R. Couriel, MD, Marcus de Lima, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, James L. Gajewski, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2004) 104 (11): 5132.
https://doi.org/10.1182/blood.V104.11.5132.5132
Published: 2004